Mechanism and drug targets for reducing cell edema (neuroprotection) and cytoplasmic excitability in astrocytes in normal and pathological states

  • Application ID: EP13173446
  • Status: APPLICATION DEEMED TO BE WITHDRAWN

Attorney

Employment test 201 - 500 employees
Company dna zacco
operating since 2001
1287.8
Headquarter in Copenhagen and 16 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Specialization

This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and G01 (MEASURING; TESTING). We found, that Coller IP Management Ltd, TransMIT GmbH, Kailuweit & Uhlemann, Bock Bieber Donath, Engel Patentanwaltskanzlei and 174 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 31.12.2014 - Publication A1 (EP2818177)